Transplant infections (3rd Ed.)

Authors:

Language: English
Cover of the book Transplant infections

Subjects for Transplant infections

Approximative price 201.60 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Publication date:
800 p. · Hardback
Transplant Infections is a practical, clinically focused reference covering the common and more unusual bacterial, viral, and fungal infections affecting patients who have received stem cell or solid organ transplants. It provides a comprehensive review of the epidemiology, diagnosis, and management of opportunistic infections and presents strategies for infection prevention and control. Highlights of the Third Edition include a chapter on new immunosuppressive agents and expanded coverage of tropical infections and West Nile virus.

INTRODUCTION TO TRANSPLANT INFECTIONS

Introduction to Hematopoietic Stem Cell Transplantation

Introduction to Solid Organ Transplantation

Immunosuppressive Agents

Common Drug Interactions Encountered in Treating Transplant-Related Infections

RISKS AND EPIDEMIOLOGY OF INFECTIONS AFTER TRANSPLANTATION

Risks and Epidemiology of Infections after Allogeneic Hematopoietic Stem Cell Transplantation

Risks and Epidemiology of Infections after Solid Organ Transplantation

Donor-Derived Infections: Incidence, Prevention and Management

Transplant Infections in Developing Countries

Risks and Epidemiology of Infections after Heart Transplantation

Risks and Epidemiology of Infections after Lung or Heart-Lung Transplantation

Infections in Kidney Transplant Recipients

Risks and Epidemiology of Infections after Pancreas or Kidney-Pancreas Transplantation

Risks and Epidemiology of Infections after Liver Transplantation

Risks and Epidemiology of Infections after Intestinal Transplantation

SPECIFIC SITES OF INFECTION

Pneumonia after Hematopoietic Stem Cell or Solid Organ Transplantation

Skin Infections after Hematopoietic Stem Cell or Solid Organ Transplantation

Central Nervous System Infections after Hematopoietic Stem Cell or Solid Organ Transplantation

Gastrointestinal Infections After Hemopoietic Stem Cell or Solid Organ Transplantation

BACTERIAL INFECTIONS

Gram-Positive and -Negative Infections after Hematopoietic Stem Cell or Solid Organ Transplantation

Typical and Atypical Mycobacterium Infections after Hematopoietic Stem Cell or Solid Organ Transplantation

Other Bacterial Infections after Hematopoietic Stem Cell or Solid Organ Transplantation

VIRAL INFECTIONS

Cytomegalovirus Infection after Stem Cell Transplantation

Cytomegalovirus Infection after Solid Organ Transplantation

Epstein-Barr Virus Infection and Lymphoproliferative Disorders after Hematopoietic Stem Cell or Solid Organ Transplantation

Herpes Simplex and Varicella-Zoster Virus Infection After Hematopoietic Stem Cell or Solid Organ Transplantation

Infections with Human Herpesvirus 6, 7 and 8 after Hematopoetic Stem Cell or Solid Organ Transplantation

Community-Acquired Respiratory Viruses after Hematopoietic Stem Cell or Solid Organ Transplantation

Adenovirus Infections in Allogenic Stem Cell Transplantation

Adenovirus Infection in Solid Organ Transplantation

Polyoma and Papilloma Virus Infections after Hematopoietic Stem Cell or Solid Organ Transplantation

Hepatitis B and C after Solid Organ Transplantation

Hepatitis B and C in Hematopoietic Stem Cell Transplantation

FUNGAL INFECTIONS

Yeast Infections after Hematopoietic Stem Cell Transplantation

Yeast Infections after Solid Organ Transplantation

Mold Infections after Hematopoietic Stem Cell Transplantation

Aspergillus and Other Mold Infections after Solid Organ Transplantation

Infections caused by Uncommon Fungi in Patients Undergoing Hematopoietic Stem Cell or Solid Organ Transplantation

Endemic Mycoses after Hematopoietic Stem Cell or Solid Organ Transplantation

OTHER INFECTIONS

Toxoplasmosis following Hematopoietic Stem Cell Transplantation

Toxoplasmosis after Solid Organ Transplantation

Parasites after Hematopoietic Stem Cell or Solid Organ Transplantation

INFECTION CONTROL

Infection Control Issues after Hematopoietic